Clinical characterization of patients developing histologically‐proven fibrosing cholestatic hepatitis C post‐liver transplantation
- 22 March 2011
- journal article
- Published by Wiley in Hepatology Research
- Vol. 41 (4), 328-339
- https://doi.org/10.1111/j.1872-034x.2011.00781.x
Abstract
Fibrosing cholestatic hepatitis C (FCH) post-liver transplantation (LT) is an uncommon disorder with extremely poor outcome. Using stringent histological criteria, we sought to identify cases of FCH to better characterize its incidence, clinical features and outcomes. From January 1991 to December 2007, 973 LT for hepatitis C virus (HCV) were performed at our center. Using the pathology database, 51 cases with a provisional diagnosis of FCH were identified. FCH was diagnosed histologically by cholestasis accompanied by thin periportal fibrous septa, ductular reaction and mild inflammation. FCH was reconfirmed in 24 recipients; seven had concurrent biliary problems. Twenty-seven cases were excluded; biopsy was unavailable in nine cases, 15 did not meet the histological criteria of FCH and three had missing clinical information. All received deceased donors at a mean age of 64.4 years (15/17 aged >50 years). Mean time from LT to FCH was 7.6 months with 16 of 17 diagnosed within 1 year of LT. At diagnosis, mean viral load was 14.4 million IU/mL, bilirubin 16.2 mg/dL, aspartate aminotransferase 262 IU/mL, alanine aminotransferase 192 IU/mL and alkaline phosphatase 299 IU/mL. All 17 patients died or required re-LT a mean of 7.8 months after the FCH diagnosis. FCH occurs infrequently and is typified by hyperbilirubinemia, donor age of more than 50 years, extremely high HCV RNA and specific histological changes occurring within the first several months post-LT with extremely poor patient and graft survival. Histology alone is not reliable for the diagnosis of FCH, especially in the setting of recurrent HCV with concurrent biliary problems.Keywords
This publication has 34 references indexed in Scilit:
- A Practical Guide to the Management of HCV Infection Following Liver TransplantationAmerican Journal of Transplantation, 2009
- Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancerWorld Journal of Gastroenterology, 2009
- Recurrent hepatitis C: Worse outcomes established, interventions still inadequateLiver Transplantation, 2007
- What determines the natural history of recurrent hepatitis C after liver transplantation?Journal of Hepatology, 2005
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infectionLiver Transplantation and Surgery, 1999
- Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?The Journal of Heart and Lung Transplantation, 1999
- CLINICAL AND HISTOLOGIC PATTERNS OF EARLY GRAFT FAILURE DUE TO RECURRENT HEPATITIS C IN FOUR PATIENTS AFTER LIVER TRANSPLANTATIONTransplantation, 1996
- Fibrosing cholestatic hepatitis and HBV after bone marrow transplantationBiomedicine & Pharmacotherapy, 1995
- Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisHepatology, 1991